$444 Million is the total value of BRIDGER MANAGEMENT, LLC's 43 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CHTR | Buy | CHARTER COMMUNICATIONS INC Ncl a | $31,935,000 | +11.2% | 68,159 | +29.4% | 7.20% | +52.8% |
| AZN | New | ASTRAZENECA PLCsponsored adr | $24,882,000 | – | 376,600 | +100.0% | 5.61% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $17,220,000 | – | 207,800 | +100.0% | 3.88% | – |
| HUM | New | HUMANA INC | $16,382,000 | – | 35,000 | +100.0% | 3.69% | – |
| SKIN | Buy | THE BEAUTY HEALTH COMPANY | $14,078,000 | -10.3% | 1,094,710 | +17.7% | 3.17% | +23.2% |
| IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $11,023,000 | -5.8% | 956,014 | +2.8% | 2.48% | +29.6% |
| PODD | New | INSULET CORP | $8,936,000 | – | 41,000 | +100.0% | 2.01% | – |
| Buy | RXSIGHT INC | $4,667,000 | +89.8% | 331,432 | +66.9% | 1.05% | +161.0% | |
| Buy | DOCEBO INC | $4,309,000 | -19.7% | 150,300 | +44.9% | 0.97% | +10.3% | |
| New | R1 RCM INC | $3,899,000 | – | 186,000 | +100.0% | 0.88% | – | |
| LIVN | Buy | LIVANOVA PLC | $3,491,000 | +9.7% | 55,890 | +43.7% | 0.79% | +50.8% |
| XENE | New | XENON PHARMACEUTICALS INC | $2,355,000 | – | 77,400 | +100.0% | 0.53% | – |
| QTRX | Buy | QUANTERIX CORP | $2,342,000 | -13.9% | 144,684 | +55.3% | 0.53% | +18.4% |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $767,000 | – | 66,300 | +100.0% | 0.17% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.